NO834463L - Fremgangsmaate til fremstilling av nye cefem-forbindelser - Google Patents

Fremgangsmaate til fremstilling av nye cefem-forbindelser

Info

Publication number
NO834463L
NO834463L NO834463A NO834463A NO834463L NO 834463 L NO834463 L NO 834463L NO 834463 A NO834463 A NO 834463A NO 834463 A NO834463 A NO 834463A NO 834463 L NO834463 L NO 834463L
Authority
NO
Norway
Prior art keywords
isomer
general formula
cephem
spectrum
carboxylate
Prior art date
Application number
NO834463A
Other languages
English (en)
Norwegian (no)
Inventor
Takao Takaya
Takashi Masugi
Takashi Ogino
Hisashi Takasugi
Hideaki Yamanaka
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB838300122A external-priority patent/GB8300122D0/en
Priority claimed from GB838317496A external-priority patent/GB8317496D0/en
Priority claimed from GB838329768A external-priority patent/GB8329768D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of NO834463L publication Critical patent/NO834463L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • C07D213/20—Quaternary compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Data Exchanges In Wide-Area Networks (AREA)
  • Use Of Switch Circuits For Exchanges And Methods Of Control Of Multiplex Exchanges (AREA)
NO834463A 1982-12-06 1983-12-05 Fremgangsmaate til fremstilling av nye cefem-forbindelser NO834463L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8234755 1982-12-06
GB838300122A GB8300122D0 (en) 1983-01-05 1983-01-05 Cephem compounds
GB838317496A GB8317496D0 (en) 1983-06-28 1983-06-28 Cephem compounds
GB838329768A GB8329768D0 (en) 1983-11-08 1983-11-08 Cephem compounds

Publications (1)

Publication Number Publication Date
NO834463L true NO834463L (no) 1984-06-07

Family

ID=27449416

Family Applications (1)

Application Number Title Priority Date Filing Date
NO834463A NO834463L (no) 1982-12-06 1983-12-05 Fremgangsmaate til fremstilling av nye cefem-forbindelser

Country Status (17)

Country Link
US (2) US4584290A (xx)
EP (1) EP0111281B1 (xx)
JP (1) JPH0639475B2 (xx)
KR (1) KR840007011A (xx)
AU (1) AU2174783A (xx)
CH (1) CH656882A5 (xx)
DE (1) DE3381627D1 (xx)
DK (1) DK554483A (xx)
ES (3) ES527790A0 (xx)
FI (1) FI834413A (xx)
FR (1) FR2537141B1 (xx)
GB (1) GB2139617B (xx)
GR (1) GR79043B (xx)
IT (1) IT1168734B (xx)
NO (1) NO834463L (xx)
OA (1) OA07602A (xx)
PT (1) PT77772B (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR79043B (xx) * 1982-12-06 1984-10-02 Fujisawa Pharmaceutical Co
DE69331576T2 (de) * 1992-09-18 2002-10-17 Otsuka Kagaku K.K., Osaka Cephem-verbindungen, verfarhren zu ihrer herstellung und diese enthaltende medikamente
WO1995025109A1 (fr) * 1994-03-17 1995-09-21 Otsuka Kagaku Kabushiki Kaisha Compose de cephem, procede d'obtention de ce compose et agent antibacterien contenant celui-ci
AU4496896A (en) * 1995-01-30 1996-08-21 Takeda Chemical Industries Ltd. Cephem compounds, their production and use
US5948774A (en) * 1995-05-29 1999-09-07 Takeda Chemical Industries, Ltd. Cephem compounds, their production and use
ES2191759T3 (es) * 1995-07-13 2003-09-16 Koninkl Philips Electronics Nv Metodo y sistema para la repeticion de datos entre agrupamientos logicamente sucesivos.
MY127641A (en) * 1995-10-12 2006-12-29 Essential Therapeutics Inc Cephalosporin antibiotics
US6025352A (en) * 1997-09-29 2000-02-15 Microcide Pharmaceuticals, Inc. Cephalosporin antibiotics
US6030965A (en) * 1997-09-30 2000-02-29 Microcide Pharmaceuticals, Inc. Cephalosporin antibiotics
AUPO973297A0 (en) * 1997-10-10 1997-11-06 Fujisawa Pharmaceutical Co., Ltd. New compound
US20050267092A1 (en) * 2002-02-28 2005-12-01 Chang-Seok Lee Novel cephalosporin compounds and process for preparing the same
EP2862569A1 (en) 2011-09-09 2015-04-22 Cubist Pharmaceuticals, Inc. Methods for treating intrapulmonary infections
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US9320740B2 (en) 2013-03-15 2016-04-26 Merck Sharp & Dohme Corp. Ceftolozane-tazobactam pharmaceutical compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
KR102226197B1 (ko) 2013-03-15 2021-03-11 머크 샤프 앤드 돔 코포레이션 세프톨로잔 항균성 조성물
WO2015035376A2 (en) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane
CN104177408B (zh) * 2014-09-12 2016-09-07 衡水衡林生物科技有限公司 （z）-2-(5-二氯磷酰氨基-1,2,4-噻二唑-3-基)-2-乙氧亚胺基乙酰氯的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1148830B (it) * 1979-05-23 1986-12-03 Rhone Poulenc Ind Tiovinil-3 cefalosporine, loro preparazione e composizioni che le contengono
FR2494280A1 (fr) * 1980-11-20 1982-05-21 Rhone Poulenc Ind Nouveaux derives de la cephalosporine et leur preparation
FR2494274A2 (fr) * 1980-11-20 1982-05-21 Rhone Poulenc Ind Nouvelles thiovinyl-3 cephalosporines, leur preparation et les medicaments qui les contiennent
GR79043B (xx) * 1982-12-06 1984-10-02 Fujisawa Pharmaceutical Co

Also Published As

Publication number Publication date
EP0111281A3 (en) 1985-07-03
FI834413A (fi) 1984-06-07
JPH0639475B2 (ja) 1994-05-25
JPS59130292A (ja) 1984-07-26
GB2139617B (en) 1986-09-24
GB8331713D0 (en) 1984-01-04
ES534202A0 (es) 1985-06-01
OA07602A (fr) 1985-03-31
AU2174783A (en) 1984-06-14
DE3381627D1 (de) 1990-07-12
US4584290A (en) 1986-04-22
FR2537141B1 (fr) 1987-02-27
DK554483D0 (da) 1983-12-01
ES8506729A1 (es) 1985-07-16
ES527790A0 (es) 1985-07-16
US4719206A (en) 1988-01-12
ES8506730A1 (es) 1985-07-16
CH656882A5 (de) 1986-07-31
EP0111281A2 (en) 1984-06-20
IT1168734B (it) 1987-05-20
IT8324035A0 (it) 1983-12-05
EP0111281B1 (en) 1990-06-06
FI834413A0 (fi) 1983-12-02
PT77772B (en) 1986-04-17
GB2139617A (en) 1984-11-14
PT77772A (en) 1984-01-01
ES534203A0 (es) 1985-07-16
KR840007011A (ko) 1984-12-04
ES8505690A1 (es) 1985-06-01
GR79043B (xx) 1984-10-02
DK554483A (da) 1984-06-07
FR2537141A1 (fr) 1984-06-08

Similar Documents

Publication Publication Date Title
NO834463L (no) Fremgangsmaate til fremstilling av nye cefem-forbindelser
EP0133678B1 (en) New cephem compounds, processes for preparation thereof and pharmaceutical compositions containing them
EP0103264B1 (en) New cephem compounds and processes for preparation thereof
US4399277A (en) 7-Amino-3-phosphonocephalosporanic acid compounds
SE450384B (sv) Nya cefemforeningar och forfarande for deras framstellning
NO822053L (no) Fremgangsmaate for fremstilling av nye cefemforbindelser, samt farmasoeytisk akseptable salter derav
US4631274A (en) Halovinyl cephem compounds
EP0145906B1 (en) Cephem compounds and processes for preparation thereof
EP0109683B1 (en) New cephem compounds and processes for preparation thereof
JPH0369354B2 (xx)
JPH05213971A (ja) 新規セフェム化合物
BE897719A (fr) Procede de preparation de composes de cephem et nouveaux produits ainsi que les compositions pharmaceutiques les renfermant
GB2186875A (en) New cephem compounds and processes for preparation thereof
BE898348A (fr) Procede de preparation de composes de cephem, nouveaux produits ainsi obtenus et compositions pharmaceutiques les renfermant.
GB2183649A (en) New cephem compounds and processes for preparation thereof